Sign in
4/A

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-000632

Options or other derivatives

  • Director acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nussbaum Ran · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-05-29 Grant or award : show line 1 in the form Stock Option (Right to Buy) +20,000 20,000 D
Loading xslF345X03/form4a-05302019_120527.xml…